Helix BioMedix Inc Receives $3,240,000 New Financing Round

  • Feed Type
  • Date
    2/12/2009
  • Company Name
    Helix BioMedix Inc
  • Mailing Address
    22118 20th Avenue SE Bothell, WA 98021
  • Company Description
    Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of bioactive peptides. Our patent estate covers six distinct classes of peptides, comprising more than 100,000 unique peptide sequences. Our primary commercial objective is to out-license proprietary peptides to entities that possess sales, marketing and/or manufacturing expertise. Our peptides appear to have both pharmaceutical as well as non-pharmaceutical uses including broad-spectrum topical anti-infectives, wound healing agents, and cosmeceutical peptide ingredients.
  • Website
    http://www.helixbiomedix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,240,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.